Comment from Anonymous

Summary: An anonymous commenter supports the proposed action to revise and improve the SUPAC guidances, arguing that the current documents are outdated and inconsistent. They recommend consolidating CMC change guidances, integrating ICH Q9 and Q12 standards, and expanding the scope to include continuous manufacturing and specific dosage form variations.